Literature DB >> 24462706

Stratification and delineation of gastric cancer signaling by in vitro transcription factor activity profiling and integrative genomics.

Jayaprakash Periasamy1, Muthulakshmi Muthuswami1, Divya Bhaskar Rao1, Patrick Tan2, Kumaresan Ganesan3.   

Abstract

Integrative functional genomic approaches are helpful in delineating the complex dysregulations in cancers. In the present study, in vitro activity profiling of 45 signaling pathway driven transcription factors in eight gastric cancer cell lines and direct comparison with genome-wide profiles of gastric tumors were performed and the integration resulted in the identification of three categories of factors/pathways: i) highly activated signaling pathways that stem from mutations are the critical oncogenic drivers, ii) constitutively activated stress responsive pathways which are activated not due to genetic alterations, and iii) consistently down-regulated nuclear receptor responsive factors. This functional profiling helps in discriminating therapeutic targets and signaling interactions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; In vitro profiling; Integrative functional genomics; Signaling pathway; Transcription factor

Mesh:

Substances:

Year:  2014        PMID: 24462706     DOI: 10.1016/j.cellsig.2014.01.017

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Development of a cell-based pathway modulator screening system to screen the targeted cancer therapeutic candidates.

Authors:  Ponmathi Panneerpandian; Kumaresan Ganesan
Journal:  Hum Cell       Date:  2021-01-06       Impact factor: 4.174

2.  Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.

Authors:  Kalaivani Kalamohan; Jayaprakash Periasamy; Divya Bhaskar Rao; Georgina D Barnabas; Srigayatri Ponnaiyan; Kumaresan Ganesan
Journal:  Mol Oncol       Date:  2014-05-09       Impact factor: 6.603

Review 3.  Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.

Authors:  Margaret L Gulley
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

4.  Foxk1 regulates cancer progression.

Authors:  Daniel J Garry; Geunho Maeng; Mary G Garry
Journal:  Ann Transl Med       Date:  2020-09

5.  Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.

Authors:  Charles S Fuchs; Josep Tabernero; Jiří Tomášek; Ian Chau; Bohuslav Melichar; Howard Safran; Mustapha A Tehfe; Dumitru Filip; Eldar Topuzov; Luis Schlittler; Anghel Adrian Udrea; William Campbell; Stephen Brincat; Michael Emig; Symantha A Melemed; Rebecca R Hozak; David Ferry; C William Caldwell; Jaffer A Ajani
Journal:  Br J Cancer       Date:  2016-09-13       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.